Market Place
Sourcing Support
FDA warns of allergic reactions with multiple sclerosis drugs
23 Jan 2025 //
FDA
Laurus Labs` arm gets Form 483 from FDA `adverse experience` probe
22 Jan 2025 //
CNBCTV
Cipla Goa facility receives form 483 with 1 observation
21 Jan 2025 //
ECONOMICTIMES
Hologic receives warning letter over Biozorb implantable marker
16 Jan 2025 //
MEDTECH DIVE
FDA boosts Philips cardiac monitor recall over missed ECG alerts
16 Jan 2025 //
FIERCE BIOTECH
FDA Data Issues Lead To CRL, Warning Letter, Shareholder Lawsuit
15 Jan 2025 //
JDSUPRA
US FDA classifies Biocon Biologics site as VAI
14 Jan 2025 //
EXPRESSPHARMA
J&J pauses Varipulse US debut following 4 reports of strokes
08 Jan 2025 //
FIERCE BIOTECH
FDA warning letter reveals production errors at Viatris plant
07 Jan 2025 //
FIERCE PHARMA
Spurious drugs worth Rs. 6.60 cr seized in Kolkata
02 Jan 2025 //
EXPRESSPHARMA
CDSCO flags two drugs as spurious, another 111 listed as NSQ
01 Jan 2025 //
EXPRESSPHARMA
FDA recall of Systane eye drops due to fungal contamination
31 Dec 2024 //
PREVENTION
Chemists selling spurious meds may face prosecution
27 Dec 2024 //
ECONOMICTIMES
FDA restricts imports of some Viatris drugs made at India facility
24 Dec 2024 //
REUTERS
AbbVie Healthcare under government lens for `violations`
23 Dec 2024 //
ECONOMICTIMES
Fagron Provides FDA Update on Wichita Inspection
23 Dec 2024 //
GLOBENEWSWIRE
Lexicon Receives Complete Response Letter for Zynquista
20 Dec 2024 //
GLOBENEWSWIRE
FDA ups Boston Scientific cryoablation recall tied to 4 deaths
20 Dec 2024 //
FIERCE BIOTECH
Auro Pharma`s Telangana unit gets 2 USFDA observations
18 Dec 2024 //
BUSINESS STD
FDA warns online vendors selling unapproved weight-loss drugs
18 Dec 2024 //
REUTERS
Cofepris suspends manufacturer after contamination causes deaths
17 Dec 2024 //
RAPS
Apitoria Pharma`s Unit V completes USFDA inspection
17 Dec 2024 //
BUSINESS STD
1,394 Batches of Drugs Recalled in 2023-24 for Failing Quality Tests
17 Dec 2024 //
ECONOMICTIMES
Indoco Remedies gets warning letter from USFDA for Goa plant
17 Dec 2024 //
ECONOMICTIMES
Aurobindo, Glenmark, Zydus Recall Products in US Over Manufacturing
15 Dec 2024 //
BUSINESS STD
Merck Manuals: What to Know About Listeria and Recent Recalls
11 Dec 2024 //
PR NEWSWIRE
Epcoritamab Monotherapy Shows High Response in Relapsed CLL Patients
08 Dec 2024 //
GLOBENEWSWIRE
3,000 drugs failed quality test in FY24; 282 were spurious
05 Dec 2024 //
ECONOMICTIMES
Applied Therapeutics` rare disease drug gets a CRL
30 Nov 2024 //
ENDPTS
CDSCO Declares 60 Drug Samples Tested In October As NSQ
28 Nov 2024 //
PHARMABIZ
One Dead, Nine Hospitalised In Gas Leak At Pharma Company
28 Nov 2024 //
BUSINESS STD
SugarMD Launches NSF Certification for Advanced Glucose Support
27 Nov 2024 //
ACCESSWIRE
Guardant prevails over Natera in false advertising case
26 Nov 2024 //
FIERCE PHARMA
Lupin recalls over 6 lakh bottles of hypertension drug in US
26 Nov 2024 //
ECONOMICTIMES
Alembic Pharma Gujarat facility gets 5 observations from USFDA
25 Nov 2024 //
BUSINESS STD
Bliss GVS Pharma’s Facilities Complete EU GMP Inspection
23 Nov 2024 //
BUSINESS STD
Drugmaker receives FDA warning letter after hindered inspection
20 Nov 2024 //
FDA
FDA Rejects Astellas’ Effort to Extend Eye Drug Izervay Use
19 Nov 2024 //
ENPTS
Supreme Court Asks Zydus to Approach Delhi HC Over Sigrima Ban
19 Nov 2024 //
ECONOMICTIMES
VBI recalls hepatitis B shot as it winds down operations
18 Nov 2024 //
FIERCE PHARMA
Endo Expands Voluntary Recall of Clonazepam Due to Mislabeling
18 Nov 2024 //
PR NEWSWIRE
Dr Reddy`s, FDC recall products in US for manufacturing issues
17 Nov 2024 //
ECONOMICTIMES
GAO takes FDA to task over lagging drug plant inspections
14 Nov 2024 //
FIERCE PHARMA
FDA slams Merz over `misleading` Instagram ad for Botox rival
14 Nov 2024 //
FIERCE PHARMA
Supreme Court Rejects Plea to Mandate Doctor on Drug Side-Effects
14 Nov 2024 //
FINANCIALXPRESS
Cipla gets 8 observations after FDA inspection at Bengaluru plant
13 Nov 2024 //
CNBCTV
PharmaTher Granted FDA Clarification for Ketamine NDA
13 Nov 2024 //
GLOBENEWSWIRE
Intercept Receives CRL from FDA Addressing OCALIVA Snda
12 Nov 2024 //
GLOBENEWSWIRE
China-Based Chemical Company Indicted for Alleged Fentanyl Manufacturi
12 Nov 2024 //
FDA
Buxton Releases Evidence of Product-Related Fraud at Assertio
11 Nov 2024 //
BUSINESSWIRE
CDSCO May Regulate Health Supplements to Stem Unapproved Claims
05 Nov 2024 //
ECONOMICTIMES
Recent CBER Warning Letters Target Unapproved Products, Violations
04 Nov 2024 //
RAPS
Dr. Reddy’s recalls thyroid drug over carcinogen concerns
04 Nov 2024 //
FIERCE PHARMA
Shilpa Medicare Falls After FDA Issues 4 Observations at Facility
31 Oct 2024 //
BUSINESS STD
Novo Nordisk Faces FDA Write-Up Over Semaglutide Plant Issues
31 Oct 2024 //
FIERCE PHARMA
Biocon Biologics` Bengaluru Unit Receives Voluntary FDA Action
30 Oct 2024 //
ECONOMICTIMES
Exactech Files for Bankruptcy After Recall Litigation
30 Oct 2024 //
REUTERS
High Court reinstates Injunction stopping sale of Zydus’ Sigrima
29 Oct 2024 //
EXPRESSPHARMA
Sai Life Sciences Receives EIRs from USFDA for R&D Facilities
28 Oct 2024 //
GLOBENEWSWIRE
CDSCO flags 49 medicine for failing quality; 4 declare as spurious
26 Oct 2024 //
ECONOMICTIMES
